Grantham, Mayo, Van Otterloo & Co (GMO)’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
NIEF
Grantham, Mayo, Van Otterloo & Co (GMO)'s G Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Genpact (G) stake by 0.42% in Q2 2026, buying an estimated $7.29K and bringing the position to 53,059 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #486.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in G in Q3 2019 and has held it in 14 quarters since. The position peaked at $7.26M in Q4 2022. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 53,059 shares of Genpact worth $1.46M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 222 Genpact shares in Q2 2026, an estimated $7.29K.
- Genpact made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #486 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Genpact in Q3 2019 and has held it in 14 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Genpact position peaked at $7.26M in Q4 2022.
- 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.